Related Experiment Video
Updated: Mar 7, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Mouse genomic screen reveals novel host regulator of metastasis
Toni Celià-Terrassa1, Yibin Kang2
1Department of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Abstract:
Tumor cells have to overcome challenges in the host tissue microenvironment to metastasize successfully to distant organs. In a recent Nature study, a genome-wide functional screen demonstrated that deficiency of the sphingosine-1-phoshate (S1P) transporter gene Spns2 in endothelium increased immune-mediated cell killing by T cells and natural killer (NK) cells, thereby suppressing metastatic colonization.
Insights
Tumor cells face microenvironment challenges to metastasize. A study found that disabling the S1P transporter gene Spns2 in endothelial cells boosts immune cell attacks, hindering cancer spread.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Metastasis requires tumor cells to navigate the host tissue microenvironment.
- Immune cells play a role in controlling tumor cell dissemination.
Purpose of the Study:
- To investigate the role of sphingosine-1-phosphate (S1P) transport in the tumor microenvironment.
- To identify host factors that regulate metastatic colonization.
Main Methods:
- Genome-wide functional screen in a mouse model.
- Analysis of endothelial cell function.
- Assessment of immune cell activity (T cells and NK cells).
Main Results:
- Deficiency in the sphingosine-1-phosphate (S1P) transporter gene Spns2 in endothelial cells was identified.
- Spns2 deficiency led to increased immune-mediated killing of tumor cells by T cells and NK cells.
- Suppression of metastatic colonization was observed in Spns2-deficient models.
Conclusions:
- Endothelial S1P transport is a critical regulator of metastatic colonization.
- Targeting Spns2 in endothelial cells represents a potential therapeutic strategy to inhibit cancer metastasis by enhancing immune surveillance.
